The prostate-specific antigen (PSA) test together with the tumor-nodes-metastasis (TNM) stage and the Gleason score of prostate biopsy [3] are considered indisputable prognostic factors to guide treatment decision-making. The gene discussed is KLK3; the disease is neoplasm.